Effects of a Synbiotic on Plasma Immune Activity Markers and Short-Chain Fatty Acids in Children and Adults with ADHD—A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Synbiotic 2000, a pre + probiotic, reduced comorbid autistic traits and emotion dysregulation in attention deficit hyperactivity disorder (ADHD) patients. Immune activity and bacteria-derived short-chain fatty acids (SCFAs) are microbiota–gut–brain axis mediators. The aim was to investigate Synbiotic 2000 effects on plasma levels of immune activity markers and SCFAs in children and adults with ADHD. ADHD patients (n = 182) completed the 9-week intervention with Synbiotic 2000 or placebo and 156 provided blood samples. Healthy adult controls (n = 57) provided baseline samples. At baseline, adults with ADHD had higher pro-inflammatory sICAM-1 and sVCAM-1 and lower SCFA levels than controls. Children with ADHD had higher baseline sICAM-1, sVCAM-1, IL-12/IL-23p40, IL-2Rα, and lower formic, acetic, and propionic acid levels than adults with ADHD. sICAM-1, sVCAM-1, and propionic acid levels were more abnormal in children on medication. Synbiotic 2000, compared to placebo, reduced IL-12/IL-23p40 and sICAM-1 and increased propionic acid levels in children on medication. SCFAs correlated negatively with sICAM-1 and sVCAM-1. Preliminary human aortic smooth-muscle-cell experiments indicated that SCFAs protected against IL-1β-induced ICAM-1 expression. These findings suggest that treatment with Synbiotic 2000 reduces IL12/IL-23p40 and sICAM-1 and increases propionic acid levels in children with ADHD. Propionic acid, together with formic and acetic acid, may contribute to the lowering of the higher-than-normal sICAM-1 levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microbiota-targeted interventions, including mixture of probiotic and prebiotic, was shown to increase propionic acid levels in children with ADHD, contributing to lowering of higher-than-normal proinflammatory intercellular adhesion molecule 1 levels in a randomized controlled trial62.”
From Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis (2025) · cites this paper as [62]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
The role of short chain fatty acids in health and disease
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425
Interactions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
Kelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
SCFA: mechanisms and functional importance in the gut
Martin-Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P., & Lapaque, N. (2021) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006916 · Cited by 1,480
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Sharon, G., Cruz, N. J., Kang, D.-W., Gandal, M. J., Wang, B., Kim, Y.-M., Zink, E. M., Casey, C. P., Taylor, B. C., Lane, C. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.004 · Cited by 1,182
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172 · cited 2×
“Higher levels of ICAM1 and VCAM-1 have also been associated with schizophrenia, depression, and bipolar disorder, and interestingly, higher ICAM-1 levels have been associated with BBB hyperpermeability [58,87].”
BackgroundAdhesion molecules and atherosclerosis
Blankenberg, S., Barbaux, S., & Tiret, L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00097-2 · Cited by 1,080
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926
Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation
Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A., & Kimura, I. (2015) · Nutrients · doi:10.3390/nu7042839 · Cited by 904
Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour
Desbonnet, L., Clarke, G., Traplin, A., O’Sullivan, O., Crispie, F., Moloney, R. D., Cotter, P. D., Dinan, T. G., & Cryan, J. F. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.04.004 · Cited by 760
Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J. A., & Colzato, L. S. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.04.003 · Cited by 671
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.035 · Cited by 644
Luczynski, P., McVey Neufeld, K.-A., Oriach, C. S., Clarke, G., Dinan, T. G., & Cryan, J. F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw020 · Cited by 632
Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
Hoyles, L., Snelling, T., Umlai, U.-K., Nicholson, J. K., Carding, S. R., Glen, R. C., & McArthur, S. (2018) · Microbiome · doi:10.1186/s40168-018-0439-y · Cited by 591
Han, J., Lin, K., Sequeira, C., & Borchers, C. H. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.11.015 · Cited by 521
Inflammation in psychiatric disorders: what comes first?
Bauer, M. E., & Teixeira, A. L. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13712 · Cited by 500
Säemann, M. D., Böhmig, G. A., Österreicher, C. H., Burtscher, H., Parolini, O., Diakos, C., Stöckl, J., Hörl, W. H., & Zlabinger, G. J. (2000) · The FASEB Journal · doi:10.1096/fj.00-0359fje · Cited by 482
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
Moschen, A. R., Tilg, H., & Raine, T. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0084-8 · Cited by 473
Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
Masi, A., Quintana, D. S., Glozier, N., Lloyd, A. R., Hickie, I. B., & Guastella, A. J. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.59 · Cited by 466
Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder
Liu, S., Li, E., Sun, Z., Fu, D., Duan, G., Jiang, M., Yu, Y., Mei, L., Yang, P., Tang, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36430-z · Cited by 457
Boets, E., Gomand, S. V., Deroover, L., Preston, T., Vermeulen, K., De Preter, V., Hamer, H. M., Van den Mooter, G., De Vuyst, L., Courtin, C. M., et al. (2017) · The Journal of Physiology · doi:10.1113/jp272613 · Cited by 443 · cited 1×
“Because plasma levels of acetate, propionate, and butyrate were reported to peak approximately 7 h after colonic administration of SCFAs [76], we tested if there was any apparent peak in plasma levels of these SCFAs, which would appear plausibly at 1–4 pm as a consequence of breakfast.”
BackgroundShort-chain fatty acids in control of energy metabolism
Hu, J., Lin, S., Zheng, B., & Cheung, P. C. K. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1245650 · Cited by 441
The influence of neuroinflammation in Autism Spectrum Disorder
Matta, S. M., Hill-Yardin, E. L., & Crack, P. J. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.04.037 · Cited by 416
Gut microbiome in ADHD and its relation to neural reward anticipation
Aarts, E., Ederveen, T. H. A., Naaijen, J., Zwiers, M. P., Boekhorst, J., Timmerman, H. M., Smeekens, S. P., Netea, M. G., Buitelaar, J. K., Franke, B., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183509 · Cited by 350
Autism-related dietary preferences mediate autism-gut microbiome associations
Yap, C. X., Henders, A. K., Alvares, G. A., Wood, D. L. A., Krause, L., Tyson, G. W., Restuadi, R., Wallace, L., McLaren, T., Hansell, N. K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.10.015 · Cited by 350
Zhu, F., Guo, R., Wang, W., Ju, Y., Wang, Q., Ma, Q., Sun, Q., Fan, Y., Xie, Y., Yang, Z., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0475-4 · Cited by 323
Self-citationAttention-Deficit/Hyperactivity Disorder
Banaschewski, T., Becker, K., Döpfner, M., Holtmann, M. H., Rösler, M., & Romanos, M. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0149 · Cited by 314
Morris, G., Berk, M., Carvalho, A., Caso, J. R., Sanz, Y., Walder, K., & Maes, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 307
Liu, Y.-W., Liong, M. T., Chung, Y.-C. E., Huang, H.-Y., Peng, W.-S., Cheng, Y.-F., Lin, Y.-S., Wu, Y.-Y., & Tsai, Y.-C. (2019) · Nutrients · doi:10.3390/nu11040820 · Cited by 260
Self-citationMacFabe, D. F. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.28177 · Cited by 259
Development of interleukin-12-producing capacity throughout childhood
Upham, J. W., Lee, P. T., Holt, B. J., Heaton, T., Prescott, S. L., Sharp, M. J., Sly, P. D., & Holt, P. G. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6583-6588.2002 · Cited by 257 · cited 1×
“A previous report has shown childhood IL-12/IL-23p40 levels to be lower than adulthood levels [78].”
BackgroundInflammation in Children and Adolescents With Neuropsychiatric Disorders: A Systematic Review
Mitchell, R. H. B., & Goldstein, B. I. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.013 · Cited by 244
Mitrea, L., Nemeş, S.-A., Szabo, K., Teleky, B.-E., & Vodnar, D.-C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.813204 · Cited by 237
Frye, R. E., Melnyk, S., & MacFabe, D. F. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.143 · Cited by 236
Anand, D., Colpo, G. D., Zeni, G., Zeni, C. P., & Teixeira, A. L. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00228 · Cited by 221
Sarris, J., Ravindran, A., Yatham, L. N., Marx, W., Rucklidge, J. J., McIntyre, R. S., Akhondzadeh, S., Benedetti, F., Caneo, C., Cramer, H., et al. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2013041 · Cited by 216
IL-23 in inflammatory bowel diseases and colon cancer
Neurath, M. F. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.12.002 · Cited by 214
Simon, E., Călinoiu, L. F., Mitrea, L., & Vodnar, D. C. (2021) · Nutrients · doi:10.3390/nu13062112 · Cited by 213
Spindler‐Vesel, A., Bengmark, S., Vovk, I., Cerovic, O., & Kompan, L. (2007) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607107031002119 · Cited by 210
Adhesion molecules in inflammatory bowel disease.
Jones, S. C., Banks, R. E., Haidar, A., Gearing, A. J., Hemingway, I. K., Ibbotson, S. H., Dixon, M. F., & Axon, A. T. (1995) · Gut · doi:10.1136/gut.36.5.724 · Cited by 197
Hamer, H. M., Jonkers, D. M. A. E., Vanhoutvin, S. A. L. W., Troost, F. J., Rijkers, G., de Bruïne, A., Bast, A., Venema, K., & Brummer, R.-J. M. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.04.002 · Cited by 193
Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
Thomas, S., & Baumgart, D. C. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0104-6 · Cited by 191
Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder
Wang, L.-J., Yang, C.-Y., Chou, W.-J., Lee, M.-J., Chou, M.-C., Kuo, H.-C., Yeh, Y.-M., Lee, S.-Y., Huang, L.-H., & Li, S.-C. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01352-2 · Cited by 174
A Review on the Role of Inflammation in Attention-Deficit/Hyperactivity Disorder
Leffa, D. T., Torres, I. L. S., & Rohde, L. A. (2018) · Neuroimmunomodulation · doi:10.1159/000489635 · Cited by 168
The Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Psychiatric Disorders
Müller, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01251 · Cited by 168
Checa-Ros, A., Jeréz-Calero, A., Molina-Carballo, A., Campoy, C., & Muñoz-Hoyos, A. (2021) · Nutrients · doi:10.3390/nu13010249 · Cited by 164
Cenit, M. C., Nuevo, I. C., Codoñer-Franch, P., Dinan, T. G., & Sanz, Y. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-0969-z · Cited by 163
Gut microbiota from persons with attention-deficit/hyperactivity disorder affects the brain in mice
Tengeler, A. C., Dam, S. A., Wiesmann, M., Naaijen, J., van Bodegom, M., Belzer, C., Dederen, P. J. W. C., Verweij, V., Franke, B., Kozicz, T., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00816-x · Cited by 162
Gut microbiota profiles in treatment-naïve children with attention deficit hyperactivity disorder
Jiang, H.-Y., Zhou, Y.-Y., Zhou, G.-L., Li, Y.-C., Yuan, J., Li, X.-H., & Ruan, B. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.03.036 · Cited by 161
Enteric short‐chain fatty acids promote proliferation of human neural progenitor cells
Yang, L. L., Millischer, V., Rodin, S., MacFabe, D. F., Villaescusa, J. C., & Lavebratt, C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14928 · Cited by 157
Self-citationZapolska‐Downar, D., Siennicka, A., Kaczmarczyk, M., Kołodziej, B., & Naruszewicz, M. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2003.11.008 · Cited by 156
DeCastro, M., Nankova, B. B., Shah, P., Patel, P., Mally, P. V., Mishra, R., & La Gamma, E. F. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.09.002 · Cited by 149
Association of Constipation and Fecal Incontinence With Attention-Deficit/Hyperactivity Disorder
McKeown, C., Hisle-Gorman, E., Eide, M., Gorman, G. H., & Nylund, C. M. (2013) · Pediatrics · doi:10.1542/peds.2013-1580 · Cited by 134
Szopinska-Tokov, J., Dam, S. A., Naaijen, J., Konstanti, P., Rommelse, N. N. J., Belzer, C., Buitelaar, J. K., Franke, B., Bloemendaal, M., Aarts, E., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8030406 · Cited by 131
Pro- and Synbiotics to Control Inflammation and Infection in Patients With Multiple Injuries
Giamarellos‐Bourboulis, E. J., Bengmark, S., Kanellakopoulou, K., & Kotzampassi, K. E. (2009) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31819d979e · Cited by 129
More than a gut feeling: the microbiota regulates neurodevelopment and behavior
Cryan, J. F., & Dinan, T. G. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.224 · Cited by 124 · cited 1×
“Preclinical studies from germ-free and antibiotic drug-treated mouse models have shown that the absence or alteration of normal gut microbiota early in life has significant effects on immune activity [6], stress responsiveness, and behaviors resembling traits of hyperactivity, depression, anxiety, autism, and obsessiv…”
BackgroundLi, L., Chang, Z., Sun, J., Garcia‐Argibay, M., Du Rietz, E., Dobrosavljevic, M., Brikell, I., Jernberg, T., Solmi, M., Cortese, S., et al. (2022) · World Psychiatry · doi:10.1002/wps.21020 · Cited by 108
Misiak, B., Wójta-Kempa, M., Samochowiec, J., Schiweck, C., Aichholzer, M., Reif, A., Samochowiec, A., & Stańczykiewicz, B. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110581 · Cited by 105
Early exposure to antibiotic drugs and risk for psychiatric disorders: a population-based study
Lavebratt, C., Yang, L. L., Giacobini, M., Forsell, Y., Schalling, M., Partonen, T., & Gissler, M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0653-9 · Cited by 103
Self-citationAttention-deficit/hyperactivity disorder during adulthood
Magnin, É., & Maurs, C. (2017) · Revue Neurologique · doi:10.1016/j.neurol.2017.07.008 · Cited by 100
Rezazadeh, L., Gargari, B. P., Jafarabadi, M. A., & Alipour, B. (2019) · Nutrition · doi:10.1016/j.nut.2018.12.011 · Cited by 92
Microbiota-immune-brain interactions: A lifespan perspective
Ratsika, A., Cruz-Pereira, J. S., Lynch, C. M. K., Clarke, G. A., & Cryan, J. F. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102652 · Cited by 90
Thomas, A. J., Ferrier, I. N., Kalaria, R. N., Davis, S., & O'Brien, J. T. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.2.129 · Cited by 83
Kumperscak, H. G., Gricar, A., Ülen, I., & Micetic-Turk, D. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00181 · Cited by 79
Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder
Richarte, V., Sánchez-Mora, C., Corrales, M., Fadeuilhe, C., Vilar-Ribó, L., Arribas, L., Garcia, E., Rosales-Ortiz, S. K., Arias-Vasquez, A., Soler-Artigas, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01504-6 · Cited by 75
Zapolska‐Downar, D., & Naruszewicz, M. (2009) · PubMed · Cited by 74
Systematic review of gut microbiota and attention-deficit hyperactivity disorder (ADHD)
Sukmajaya, A. C., Lusida, M. I., Soetjipto, & Setiawati, Y. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-021-00330-w · Cited by 74
Skott, E., Yang, L. L., Stiernborg, M., Söderström, Å., Rȕegg, J., Schalling, M., Forsell, Y., Giacobini, M., & Lavebratt, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.056 · Cited by 73
Self-citationCyclooxygenase-2 Is an Obligatory Factor in Methamphetamine-Induced Neurotoxicity
Thomas, D. M., & Kuhn, D. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080242 · Cited by 62
Yarur, A. J., Quintero, M. A., Jain, A., Czul, F., Barkin, J. S., & Abreu, M. T. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000991 · Cited by 61
Thomas, A. J., Davis, S., Ferrier, I. N., Kalaria, R. N., & O'Brien, J. T. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.015 · Cited by 53
Vidot, H., Cvejic, E., Finegan, L. J., Shores, E. A., Bowen, D. G., Strasser, S. I., McCaughan, G. W., Carey, S., Allman-Farinelli, M., & Shackel, N. A. (2019) · Nutrients · doi:10.3390/nu11081810 · Cited by 48
Schmidt, C., Hulthe, J., & Fagerberg, B. (2008) · Angiology · doi:10.1177/0003319708316899 · Cited by 47
Plaudis, H., Pupelis, G., Zeiza, K., & Boka, V. (2012) · Acta chirurgica Belgica · doi:10.1080/00015458.2012.11680811 · Cited by 44
Liu, W., Yang, M.-C., Wu, Y.-Y., Chen, P.-H., Hsu, C.-M., & Chen, L.-W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196511 · Cited by 39
Self-citationLower plasma concentrations of short-chain fatty acids (SCFAs) in patients with ADHD
Yang, L. L., Stiernborg, M., Skott, E., Gillberg, T., Landberg, R., Giacobini, M., & Lavebratt, C. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.09.042 · Cited by 39
Self-citationMeixensberger, S., Kuzior, H., Fiebich, B. L., Süß, P., Runge, K., Berger, B., Nickel, K., Denzel, D., Schiele, M. A., Michel, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11071134 · Cited by 38
Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia
Bedrossian, N., Haidar, M., Fares, J., Kobeissy, F. H., & Fares, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00016 · Cited by 37
Haghighat, N., Mohammadshahi, M., Shayanpour, S., & Haghighizadeh, M. H. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9477-9 · Cited by 37
Thomas, A. J., Ferrier, I. N., Kalaria, R. N., Davis, S., & O'Brien, J. T. (2002) · The British Journal of Psychiatry · doi:10.1017/s0007125000161847 · Cited by 37
Cabrera, S. M., Coren, A. T., Pant, T., Ciecko, A. E., Jia, S., Roethle, M. F., Simpson, P. M., Atkinson, S. N., Salzman, N. H., Chen, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07203-6 · Cited by 36
Chronic oral methylphenidate treatment increases microglial activation in rats
Carias, E., Hamilton, J., Robison, L. S., Delis, F., Eiden, R. D., Quattrin, T., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1931-z · Cited by 32
Yang, L. L., Stiernborg, M., Skott, E., Söderström, Å., Giacobini, M., & Lavebratt, C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.10.005 · Cited by 29
Self-citationCoelho‐Santos, V., Cardoso, F. L., Magalhães, A., Ferreira-Teixeira, M., Leitão, R. A., Gomes, C. M. F., Rito, M., Barbosa, M., Ribeiro, C., & Silva, A. P. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.007 · Cited by 28
Leffa, D. T., Caye, A., Santos, I. S., Matijasevich, A., Menezes, A. M. B., Wehrmeister, F. C., Oliveira, I. O., Vitola, E. S., Bau, C. H. D., Grevet, E. H., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.004 · Cited by 28
Wipfler, P., Heikkinen, A., Harrer, A., Pilz, G., Kunz, A. B., Golaszewski, S. M., Reuß, R., Oschmann, P., & Kraus, J. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6622-3 · Cited by 26
Valvassori, S. S., Dal-Pont, G. C., Tonin, P. T., Varela, R. B., Ferreira, C. L., Gava, F. F., Andersen, M. L., Soares, J. C., & Quevedo, J. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.009 · Cited by 25
Szopinska-Tokov, J., Dam, S. A., Naaijen, J., et al. (2020) · Preprints.org · doi:10.20944/preprints202002.0082.v1 · Cited by 25
Otten, K., Keller, L., Puiu, A. A., Herpertz‐Dahlmann, B., Seitz, J., Kohn, N., Edgar, J. C., Wagels, L., & Konrad, K. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104776 · Cited by 21
Alaşehirli, B., Oğuz, E., Gökçen, C., Erbağcı, A. B., Örkmez, M., & Demiryürek, A. T. (2015) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217415605040 · Cited by 16
Mora, S., Martín-González, E., Prados-Pardo, Á., Moreno, J., López, M. J., Pilar-Cuéllar, F., Castro, E., Díaz, Á., Flores, P., & Moreno, M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.08.010 · Cited by 14
Yoshida, A., Takahashi, H. K., Iwagaki, H., Yoshino, T., Morichika, T., Yokoyama, M., Itoh, H., Mori, S., Akagi, T., Nishibori, M., et al. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0518-6 · Cited by 10
Enkhmaa, B., Anuurad, E., Zhang, W., Kim, K., & Berglund, L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.023 · Cited by 9
[The gut-brain axis in attention deficit hyperactivity disorder: the role of the microbiota].
Vanesa Richarte, B., Rosales, K. D. C. U., Montse Corrales, F., Bellina, M., Fadeuilhe, C., Calvo, E., Ibáñez, P., Sánchez‐Mora, C., Ribasés, M., & Ramos‐Quiroga, J. A. (2018) · PubMed · Cited by 6
Attention-Deficit Hyperactivity Disorder
Fayyad, J. A., Haro, J. M., Aguilar‐Gaxiola, S., & Kessler, R. C. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316336168.014 · Cited by 5
Cited by
Beyond the gut: decoding the gut–immune–brain axis in health and disease
Park, J. C., Chang, L., Kwon, H.-K., & Im, S.-H. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01333-3 · Cited by 149
“MBTs have been extensively studied in ASD, where ↑ P r o p i o n i c A c i d i n b l oo d [ 378 ] in fl ammation and microbial dysbiosis are key pathological features.”
Short-chain fatty acids (SCFAs) in gut health: Implications for drug metabolism and therapeutics
Sankarganesh, P., Bhunia, A., Kumar, A. G., Babu, A. S., Gopukumar, S. T., & Elumalai, L. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100139 · Cited by 141
The gut microbiota–brain axis in neurological disorders
You, M., Chen, N., Yang, Y., Cheng, L., He, H., Cai, Y., Liu, Y., Liu, H., & Hong, G. (2024) · MedComm · doi:10.1002/mco2.656 · Cited by 132
“167 Since some participants were still using ADHD medications, the alterations in plasma immune activity markers in ADHD patients could be attributed to the influence of these medications or the age and gender of the patients.”
BackgroundInfluentialLi, L., Yang, C., Jia, M., Wang, Y., Zhao, Y., Li, Q., Gong, J., He, Y., Xu, K., Liu, X., et al. (2024) · Food & Function · doi:10.1039/d4fo00886c · Cited by 54
Schnorr, I., Siegl, A., Luckhardt, S., Wenz, S., Friedrichsen, H., Jomaa, H. E., Steinmann, A., Kilencz, T., Arteaga-Henríquez, G., Ramos-Sayalero, C., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02729-3 · Cited by 46
“To our knowledge, up to date, only limited studies in adults exist regarding in fl ammatory proteins [25 – 28].”
BackgroundSelf-citation
Metadata
- Authors
- Yang, L. L., Stiernborg, M., Skott, E., Xu, J., Wu, Y., Landberg, R., Arefin, S., Kublickiene, K., Millischer, V., Nilsson, I. A. K., Schalling, M., Giacobini, M., & Lavebratt, C.
- Affiliations
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Chalmers University of Technology (SE)
- Corresponding author
- Lavebratt, Catharina
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-03-06
- Volume
- 15
- Issue
- 5
- Pages
- 1293
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10004766
- OpenAlex
- W4323313105
- Cited by
- 42
- References
- 104
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 14 · 2023: 3
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Chalmers Research (Chalmers University of Technology) (submittedVersion)
- Funders
- Swedish Research Council (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
- Swedish Brain Foundation (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
- Ekhaga Foundation (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
- the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
- Lindhés Advokatbyrå AB (2014-10171, FO2020-0305, FO2021-0412, 2016-47, SLL20190589, LA2019-0013, LA2020-0006)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- synbiotics, attention deficit hyperactivity disorder, short-chain fatty acids, propionic acid, sICAM-1, sVCAM-1, IL-2 receptor alpha, microbiota-gut-brain axis, prebiotics, probiotics, children, adults, ADHD medication, ICAM-1 expression, autism spectrum disorder comorbidity, emotional dysregulation
- MeSH terms
- Adult, Attention Deficit Disorder with Hyperactivity, Child, Fatty Acids, Volatile, Humans, Propionates, Biomarkers, Interleukin-12, Synbiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.